These webcasts and presentations contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, regulatory approvals, market position, expenditures, impact of acquisitions and dispositions, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "plan," "expect," , "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.

If underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed in these forward-looking statements. Risks and uncertainties include, but are not limited to: economic and financial market factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in product development, including uncertainty of clinical success and obtaining regulatory approvals; challenges to patents; the impact of patent expirations; uncertainty of commercial success of new and existing products; significant adverse litigation or government action, including related to product liability claims; the ability of the company to successfully execute strategic plans including restructuring plans; the impact of business combinations and divestitures and the possibility that the expected benefits and opportunities of an acquisition are not realized in the anticipated time frame or at all; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; financial instability of international economies and legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; increased scrutiny of the health care industry by government agencies; product efficacy or safety concerns resulting in product recalls or regulatory action; and the potential failure to meet obligations in compliance agreements with government bodies.

A further list and description of these risks, uncertainties and other factors can be found in the company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors,” and in the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, on this Internet site (www.jnj.com) under “Investors—SEC Filings,” or on request from Johnson & Johnson. Information in each of these presentations is as of the dates and time periods indicated therein, and the company does not undertake to update any of the information contained in these materials. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED WEBCASTS OR ON DEMAND VIDEOS.

Webcasts on this website are the property of Johnson & Johnson. Any redistribution, retransmission or rebroadcast of this webcast in any form without the express written consent of Johnson & Johnson is strictly prohibited. Please see our Legal Notice for more information about the content of this website and copyright laws.

Webcasts & Presentations

Upcoming Events
Archived Events
Date Event Details
Oct 13, 2020 at 8:30 AM EDT
Johnson & Johnson Third Quarter Earnings Call and Webcast
Sep 16, 2020 at 10:15 AM EDT
18th Annual Morgan Stanley Virtual Global Healthcare Conference
Sep 09, 2020 at 10:40 AM EDT
Wells Fargo 2020 Virtual Healthcare Conference
Sep 08, 2020 at 1:20 PM EDT
Barclays Global Consumer Staples Conference
Jul 27, 2020 at 3:00 PM EDT
Citi ‘Of Hearts and Minds’ Conference Call Series
This conference replay will be available to investors and other interested parties by dialing: (719) 457-0820 Passcode: 9339323 and will be available through Monday, August 3 at 2:00PM ET.
Jul 17, 2020
James List, M.D, Ph.D, Global Therapeutic Area Head, Janssen R&D Provides an Overview on Janssen’s Mission to Preserve and Restore Vision
Jul 16, 2020 at 8:00 AM EDT
Johnson & Johnson Second Quarter Earnings Call and Webcast UPDATED
Jun 23, 2020 at 2:30 PM EDT
Bank of America Virtual Conference
Jun 18, 2020 at 8:00 AM EDT
Health for Humanity Webcast
Jun 10, 2020 at 11:20 AM EDT
Goldman Sachs 41st Annual Global Healthcare Conference
May 27, 2020 at 10:00 AM EDT
Bernstein's 36th Annual Strategic Decisions Virtual Conference
May 19, 2020 at 8:00 AM EDT
Dr. Peter Lebowitz (Oncology Global Therapeutic Area Head) & Louise Chen (Cantor Fitzgerald) Virtual Oncology Fireside Chat
Apr 23, 2020 at 10:00 AM EDT
Johnson & Johnson 2020 Annual Meeting of Shareholders
Apr 14, 2020 at 8:30 AM EDT
Johnson & Johnson First Quarter Earnings Call and Webcast
Mar 11, 2020 at 10:15 AM EDT
Barclays Global Healthcare Conference
Mar 02, 2020 at 11:20 AM EST
Cowen and Company 40th Annual Health Care Conference
Feb 26, 2020 at 2:00 PM EST
9th Annual SVB Leerink Global Healthcare Conference
Jan 22, 2020 at 8:00 AM EST
Johnson & Johnson Fourth Quarter Earnings Call and Webcast UPDATED
Jan 13, 2020 at 5:30 PM EST
38th Annual JP Morgan Health Care Conference

Cautionary Statement                         

These webcasts and presentations contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, regulatory approvals, market position, expenditures, impact of acquisitions and dispositions, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "plan," "expect," , "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.

If underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed in these forward-looking statements. Risks and uncertainties include, but are not limited to: economic and financial market factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in product development, including uncertainty of clinical success and obtaining regulatory approvals; challenges to patents; the impact of patent expirations; uncertainty of commercial success of new and existing products; significant adverse litigation or government action, including related to product liability claims; the ability of the company to successfully execute strategic plans including restructuring plans; the impact of business combinations and divestitures and the possibility that the expected benefits and opportunities of an acquisition are not realized in the anticipated time frame or at all; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; financial instability of international economies and legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; increased scrutiny of the health care industry by government agencies; product efficacy or safety concerns resulting in product recalls or regulatory action; and the potential failure to meet obligations in compliance agreements with government bodies.

A further list and description of these risks, uncertainties and other factors can be found in the company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors,” and in the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, on this Internet site (www.jnj.com) under “Investors—SEC Filings,” or on request from Johnson & Johnson. Information in each of these presentations is as of the dates and time periods indicated therein, and the company does not undertake to update any of the information contained in these materials. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED WEBCASTS OR ON DEMAND VIDEOS.

Webcasts on this website are the property of Johnson & Johnson. Any redistribution, retransmission or rebroadcast of this webcast in any form without the express written consent of Johnson & Johnson is strictly prohibited. Please see our Legal Notice for more information about the content of this website and copyright laws.

This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.